Drug Shortage Report for TEVA-ALENDRONATE
| Report ID | 43116 |
| Drug Identification Number | 02261715 |
| Brand name | TEVA-ALENDRONATE |
| Common or Proper name | ALENDRONATE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ALENDRONIC ACID |
| Strength(s) | 70MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 4 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-03-01 |
| Estimated end date | 2018-08-10 |
| Actual end date | 2018-09-15 |
| Shortage status | Resolved |
| Updated date | 2018-10-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-03-16 | English | Compare |
| v2 | 2018-03-16 | French | Compare |
| v3 | 2018-05-30 | English | Compare |
| v4 | 2018-05-30 | French | Compare |
| v5 | 2018-10-11 | English | Compare |
| v6 | 2018-10-11 | French | Compare |
Showing 1 to 6 of 6